Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind, Randomized Clinical Trial With Active Controls to Assess Safety, Immunogenicity and Lot-to-lot Consistency of Inactivated Split-virion Quadrivalent Influenza Vaccine of Butantan Institute

NCT03927131 is registered in ClinicalTrials.gov with Butantan Institute as lead sponsor.

NCT NCT03927131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03927131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind, Randomized Clinical Trial With Active Controls to Assess Safety, Immunogenicity and Lot-to-lot Consistency of Inactivated Split-virion Quadrivalent Influenza Vaccine of Butantan Institute
Lead sponsor
Butantan Institute
Phase
Phase 3
Overall status
Completed
Start date
May 12, 2021
Completion date
March 13, 2024
Enrollment
5,822 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, human